daunorubicin has been researched along with Cirrhosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Arao, Y; Fujimoto, K; Fukaya, K; Furusawa, K; Haga, T; Hiraiwa, H; Kano, N; Kato, H; Kondo, T; Kuwayama, T; Morimoto, R; Murohara, T; Mutsuga, M; Oishi, H; Okumura, T; Sawamura, A; Shimizu, S; Sugiura, Y; Usui, A; Watanabe, N; Yamaguchi, S; Yokoi, T | 1 |
| Adamcová, M; Holečková, M; Jirkovská, A; Karabanovich, G; Kocúrová-Lengvarská, J; Kollárová-Brázdová, P; Kubeš, J; Lenčová-Popelová, O; Mazurová, Y; Roh, J; Šimůnek, T; Štěrba, M; Štěrbová-Kovaříková, P; Váňová, N | 1 |
| Abdelhamid, G; Alammari, AH; Althurwi, HN; Dawood, D; El-Kadi, AOS; El-Sherbeni, AA; Elshenawy, OH; Maayah, ZH; McGinn, E | 1 |
| Afrin, R; Arumugam, S; Harima, M; Karuppagounder, V; Nakamura, M; Pitchaimani, V; Sreedhar, R; Suzuki, H; Suzuki, K; Thandavarayan, RA; Ueno, K; Watanabe, K | 1 |
| Ilbay, G; Ilbay, K; Vural, E; Yilmaz, M | 1 |
| Adamcová, M; Aupperle, H; Geršl, V; Mazurová, Y; Popelová, O; Potáčová, A; Štěrba, M | 1 |
6 other study(ies) available for daunorubicin and Cirrhosis
| Article | Year |
|---|---|
Pathological changes of the myocardium in reworsening of anthracycline-induced cardiomyopathy after explant of a left ventricular assist device.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cardiotoxicity; Daunorubicin; Device Removal; Disease Progression; Female; Fibrosis; Heart-Assist Devices; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Myocardium; Time Factors; Ventricular Function, Left | 2020 |
Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo.
Topics: Animals; Cardiomyopathies; Cardiotoxicity; Chronic Disease; Daunorubicin; Diketopiperazines; Disease Models, Animal; DNA Damage; Fibrosis; HL-60 Cells; Humans; Male; Myocytes, Cardiac; Prodrugs; Rabbits; Topoisomerase II Inhibitors; Tumor Suppressor Protein p53; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2021 |
The Role of Soluble Epoxide Hydrolase Enzyme on Daunorubicin-Mediated Cardiotoxicity.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomegaly; Cardiotoxicity; Cells, Cultured; Cytochrome P-450 Enzyme System; Daunorubicin; Disease Models, Animal; Enzyme Inhibitors; Epoxide Hydrolases; Fibrosis; Humans; Hydroxyeicosatetraenoic Acids; Male; Myocytes, Cardiac; NF-kappa B p50 Subunit; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Rats, Sprague-Dawley; Signal Transduction | 2018 |
Naringenin ameliorates daunorubicin induced nephrotoxicity by mitigating AT1R, ERK1/2-NFκB p65 mediated inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibiotics, Antineoplastic; Apoptosis; Daunorubicin; Endoplasmic Reticulum Stress; Fibrosis; Flavanones; Inflammation; Injections, Intravenous; Kidney Diseases; Male; MAP Kinase Signaling System; PPAR gamma; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renal Agents; Transcription Factor RelA | 2015 |
Prevention of Epidural Fibrosis in Rats by Local Administration of Mitomycin C or Daunorubicin.
Topics: Animals; Antibiotics, Antineoplastic; Cicatrix; Daunorubicin; Disease Models, Animal; Female; Fibrosis; Mitomycin; Neurosurgical Procedures; Peripheral Nerves; Rats; Sciatic Nerve; Tissue Adhesions | 2016 |
Cardiac remodeling and MMPs on the model of chronic daunorubicin-induced cardiomyopathy in rabbits.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Cardiovascular Agents; Chronic Disease; Collagen; Daunorubicin; Disease Models, Animal; Drug Interactions; Fibrosis; Hydroxyproline; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardium; Rabbits; Razoxane; Ventricular Remodeling | 2010 |